Understanding early stages of pulmonary fibrosis in families
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
This study is looking at how pulmonary fibrosis starts in families with a history of lung issues, aiming to find out what genes and environmental factors might play a role before serious damage happens, so if you have a family member with interstitial pneumonia, you could help us learn more about this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10898872 on NIH RePORTER |
What this research studies
This research investigates the early stages of pulmonary fibrosis, a serious lung condition, by studying families with a history of interstitial pneumonia. It aims to identify genetic and environmental factors that contribute to the disease before irreversible lung damage occurs. By analyzing a cohort of first-degree relatives of affected individuals, the study seeks to uncover the different subtypes of the disease and their progression. Patients will be monitored and assessed to gather data on their health and potential risk factors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have a first-degree relative with interstitial pneumonia and are currently unaffected.
Not a fit: Patients without a family history of interstitial pneumonia or those already diagnosed with advanced pulmonary fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and targeted prevention strategies for pulmonary fibrosis.
How similar studies have performed: Previous research has shown promise in understanding genetic and environmental interactions in similar pulmonary conditions, suggesting potential for success in this approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Schwartz, David Albert — University of Colorado Denver
- Study coordinator: Schwartz, David Albert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.